<DOC>
	<DOCNO>NCT00179855</DOCNO>
	<brief_summary>The purpose research study evaluate safety feasibility extracorporeal photopheresis ( ECP ) treatment steroid-refractory acute graft-versus-host disease ( GVHD ) child .</brief_summary>
	<brief_title>Extracorporeal Photopheresis Acute Graft Versus Host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<criteria>Statuspost allogeneic stem cell transplant ( include cord blood transplant , matchedunrelateddonor transplant matchedrelated donor transplant ) indication . HLA match need 46/6 least intermediate resolution class I + II cord blood 56/6 match relate matched unrelated donor . Diagnosis grade IIIV acute GVHD histological confirmation least one organ ( skin , gut , liver ) within last 14 day . Grading acute GVHD per standard Keystone criterion . Prior enrollment , effort make rule diagnosis may mimic GVHD , drug rash GI infection . Patients treat acute GVHD appear progress chronic GVHD also eligible No improvement , worsen , acute GVHD least 4 day IV methylprednisolone dose , least 2.0mg/kg/day.. Weight &gt; 25.0kg . Adequate venous access . Evidence venoocclusive disease . Intubated patient . Patient receive dialysis . Age &gt; 30 . Total bilirubin &gt; 15mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>graft versus host disease</keyword>
	<keyword>ECP</keyword>
	<keyword>extracorporeal photopheresis</keyword>
	<keyword>allogeneic transplantation</keyword>
</DOC>